Nasdaq · Healthcare

Jaguar Health, Inc. (JAGX)

As-reported financials and recent SEC filings for Jaguar Health, Inc., latest fiscal period FY2025. Every figure is pulled straight from the company’s EDGAR filings — no estimates.

Snapshot

Revenue

$11.5M

Net income

$-53.6M

Net margin

—

Diluted EPS

$-22.97

ROE

286.7%

P/E (TTM)

—

Market cap

—

Debt / equity

—

Income statement (as reported)

Line	FY2025	FY2024	FY2023	FY2023	FY2024
Revenue	$11.5M	$11.7M	$9.8M	$12.0M	$4.3M
Gross profit	$7.7M	$9.7M	$7.7M	$9.9M	$2.0M
Operating income	$-45.9M	$-30.8M	$-34.3M	$-34.4M	$-40.7M
Net income	$-53.6M	$-38.5M	$-41,900	$-48,400	$-52,600
Diluted EPS	$-22.97	$-16.34	$-17.62	$-20.23	$-24.67

Source: company XBRL financial statements on SEC EDGAR.

Recent SEC filings

8-K2026-07-01

D2026-07-01

D2026-07-01

8-K2026-06-25

8-K/A2026-06-22

8-K2026-06-22

8-K2026-06-18

8-K2026-06-11

Largest Healthcare peers

UNH

UNITEDHEALTH GROUP INC

All Healthcare companies →

Go deeper on JAGX

Search Jaguar Health, Inc.’s filings with cited answers, compare it against peers, build an operating model, and track it in your portfolio — all in one place.

Start free

Or check your whole portfolio free — no account needed.

Data sourced from SEC EDGAR (public domain). Figures are as-reported and may be unaudited or restated; verify against the source filing before relying on them. Informational only — not investment advice.